|
HERC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82295999999749E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.56769999999962E-05 |
| Normal-vs-Stage2 |
1.356560E-01 |
| Normal-vs-Stage3 |
1.64676999999669E-05 |
| Normal-vs-Stage4 |
2.365100E-04 |
| Stage1-vs-Stage2 |
1.405410E-01 |
| Stage1-vs-Stage3 |
1.222990E-01 |
| Stage1-vs-Stage4 |
3.644400E-01 |
| Stage2-vs-Stage3 |
2.006100E-02 |
| Stage2-vs-Stage4 |
7.086200E-02 |
| Stage3-vs-Stage4 |
8.094400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72184999999159E-05 |
| Normal-vs-AfricanAmerican |
1.868200E-01 |
| Normal-vs-Asian |
8.755600E-04 |
| Caucasian-vs-AfricanAmerican |
1.812160E-01 |
| Caucasian-vs-Asian |
8.719600E-01 |
| AfricanAmerican-vs-Asian |
3.215600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.54230000016487E-07 |
| Normal-vs-Female |
1.356770E-04 |
| Male-vs-Female |
4.309800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.5608999999941E-05 |
| Normal-vs-Age(41-60Yrs) |
1.030800E-04 |
| Normal-vs-Age(61-80Yrs) |
5.167700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.121400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.106400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.891800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.918200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.118200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.779000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.877800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.062500E-02 |
| Classical-VS-Follicular |
4.357300E-04 |
| Classical-VS-Other |
9.732200E-01 |
| Classical-VS-Normal |
2.13739999999074E-05 |
| Tall-VS-Follicular |
5.864599999994E-05 |
| Tall-VS-Other |
4.133800E-01 |
| Tall-VS-Normal |
4.8402000000225E-06 |
| Follicular-VS-Other |
2.712400E-01 |
| Follicular-VS-Normal |
5.746000E-01 |
| Other-VS-Normal |
7.440300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.226900E-04 |
| Normal-vs-N1 |
1.99300000003344E-06 |
| N0-vs-N1 |
2.411500E-02 |
|
|
